🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 12/03/2015 | 0,4294 USD |
| 11/12/2014 | 0,4294 USD |
| 11/09/2014 | 0,4198 USD |
| 12/06/2014 | 0,4198 USD |
| 13/03/2014 | 0,4198 USD |
| 12/12/2013 | 0,4198 USD |
| 12/09/2013 | 0,4103 USD |
| 13/06/2013 | 0,4103 USD |
| 13/03/2013 | 0,4103 USD |
| 13/12/2012 | 0,4103 USD |
| 13/09/2012 | 0,4008 USD |
| 13/06/2012 | 0,4008 USD |
| 13/03/2012 | 0,4008 USD |
| 13/12/2011 | 0,4008 USD |
| 13/09/2011 | 0,3626 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 07/07/2014 | 56,21 | 56,92 | 55,81 | 55,84 | -1,15% | 1,97% | 9.721.458 |
| 03/07/2014 | 56,67 | 56,73 | 56,36 | 56,49 | +0,25% | 0,64% | 5.470.665 |
| 02/07/2014 | 55,79 | 56,39 | 55,70 | 56,35 | +0,92% | 1,25% | 7.274.168 |
| 01/07/2014 | 55,06 | 55,95 | 54,85 | 55,83 | +1,14% | 2,01% | 9.262.224 |
| 30/06/2014 | 54,97 | 55,53 | 54,90 | 55,20 | +0,56% | 1,16% | 9.154.280 |
| 27/06/2014 | 55,70 | 55,84 | 54,85 | 54,90 | -1,71% | 1,78% | 18.115.414 |
| 26/06/2014 | 56,07 | 56,08 | 55,58 | 55,85 | -0,56% | 0,88% | 7.585.738 |
| 25/06/2014 | 55,09 | 56,60 | 55,08 | 56,16 | +1,62% | 2,77% | 13.911.466 |
| 24/06/2014 | 55,71 | 56,07 | 55,23 | 55,27 | -0,99% | 1,51% | 8.550.108 |
| 23/06/2014 | 56,12 | 56,28 | 55,73 | 55,82 | -0,71% | 0,97% | 7.393.011 |
| 20/06/2014 | 55,93 | 56,56 | 55,76 | 56,22 | +1,06% | 1,43% | 15.110.064 |
| 19/06/2014 | 55,74 | 55,74 | 55,44 | 55,63 | -0,19% | 0,55% | 6.300.471 |
| 18/06/2014 | 55,37 | 55,77 | 55,16 | 55,73 | +0,60% | 1,10% | 8.213.176 |
| 17/06/2014 | 55,30 | 55,55 | 55,13 | 55,40 | -0,02% | 0,76% | 6.567.502 |
| 16/06/2014 | 55,40 | 55,71 | 55,09 | 55,41 | -0,29% | 1,12% | 8.102.612 |
| 13/06/2014 | 55,45 | 55,96 | 55,32 | 55,57 | -0,10% | 1,15% | 8.801.628 |
| 12/06/2014 | 55,61 | 56,03 | 55,40 | 55,63 | -0,87% | 1,13% | 10.022.967 |
| 11/06/2014 | 55,84 | 56,33 | 55,73 | 56,12 | +0,55% | 1,08% | 12.258.246 |
| 10/06/2014 | 55,27 | 55,82 | 55,27 | 55,81 | +0,95% | 1,00% | 8.031.558 |
| 09/06/2014 | 54,86 | 55,31 | 54,62 | 55,29 | +0,16% | 1,27% | 8.470.879 |
| 06/06/2014 | 55,53 | 55,59 | 55,04 | 55,20 | -0,43% | 1,00% | 7.024.954 |
| 05/06/2014 | 55,31 | 55,79 | 55,08 | 55,44 | +0,29% | 1,29% | 8.007.349 |
| 04/06/2014 | 55,13 | 55,35 | 54,88 | 55,28 | +0,03% | 0,87% | 7.205.419 |
| 03/06/2014 | 54,89 | 55,31 | 54,74 | 55,26 | -0,03% | 1,03% | 7.417.849 |
| 02/06/2014 | 55,26 | 55,53 | 54,85 | 55,28 | +0,12% | 1,24% | 6.733.924 |
| 30/05/2014 | 54,89 | 55,60 | 54,89 | 55,21 | +0,28% | 1,30% | 12.071.912 |
| 29/05/2014 | 54,30 | 55,14 | 54,01 | 55,06 | +2,31% | 2,09% | 8.922.358 |
| 28/05/2014 | 54,11 | 54,13 | 53,82 | 53,82 | -0,51% | 0,58% | 7.171.569 |
| 27/05/2014 | 54,32 | 54,43 | 53,88 | 54,09 | -0,21% | 1,00% | 7.652.286 |
| 23/05/2014 | 54,04 | 54,37 | 53,86 | 54,21 | +0,57% | 0,94% | 6.343.544 |